Cargando…

Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review)

Nasopharyngeal carcinoma (NPC) is an epithelial tumor located in the nasopharynx and is highly associated with Epstein-Barr virus (EBV) infection. Although radiotherapy alone can cure ~90% of patients with early-stage disease, >70% of patients with NPC have locoregionally advanced or metastatic d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Huageng, Yao, Yuyi, Deng, Xinyi, Huang, Zongyao, Chen, Yungchang, Wang, Zhao, Hong, Huangming, Huang, He, Lin, Tongyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367053/ https://www.ncbi.nlm.nih.gov/pubmed/37417358 http://dx.doi.org/10.3892/ijo.2023.5545

Ejemplares similares

Characteristics of immunotherapy trials for nasopharyngeal carcinoma over a 15-year period
por: Huang, Huageng, et al.
Publicado: (2023)

Proposed prognostic subgroups and facilitated clinical decision-making for additional locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: a retrospective study based on recursive partitioning analysis
por: Yao, Yuyi, et al.
Publicado: (2023)

A study on the prevention of hemorrhage and perforation in patients with primary gastric diffuse large‐B cell lymphoma during treatment with immunochemotherapy
por: Zhang, Limei, et al.
Publicado: (2023)

Current status and advances of immunotherapy in nasopharyngeal carcinoma
por: Xu, Jian-Ying, et al.
Publicado: (2022)

Surgery and Chemotherapy versus Chemotherapy Only in Older Persons with Primary Intestinal Diffuse Large B-Cell Lymphoma
por: Zhang, Limei, et al.
Publicado: (2021)

Clinical features and treatment outcome of lymphoepithelioma-like carcinoma from multiple primary sites: a population-based, multicentre, real-world study
por: Chen, Meiting, et al.
Publicado: (2022)

Long-Term Survival of Patients With Chemotherapy-Naïve Metastatic Nasopharyngeal Carcinoma Receiving Cetuximab Plus Docetaxel and Cisplatin Regimen
por: Zhang, Mengping, et al.
Publicado: (2020)

A novel prognostic nomogram for patients with extragastric mucosa‐associated lymphoid tissue lymphoma: A multicenter study
por: Li, Xiaoqian, et al.
Publicado: (2022)

KIF15 is involved in development and progression of Burkitt lymphoma
por: Wang, Zhao, et al.
Publicado: (2021)

Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects
por: Liu, Zhuoyan, et al.
Publicado: (2021)

Chemotherapy Plus Radiotherapy Versus Chemotherapy Alone for Patients With Peripheral T-Cell Lymphoma, Not Otherwise Specified
por: Chen, Zegeng, et al.
Publicado: (2021)

Predictive Biomarkers for Immunotherapy in Gastric Cancer: Current Status and Emerging Prospects
por: Hou, Wanting, et al.
Publicado: (2023)

Current Status and Prospects of Immunotherapy for Gynecologic Melanoma
por: Anko, Mayuka, et al.
Publicado: (2021)

Quantitative study of cytotoxic T-lymphocyte immunotherapy for nasopharyngeal carcinoma
por: Shengjun, Wang, et al.
Publicado: (2012)

Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma
por: Zhao, Ming, et al.
Publicado: (2023)

Retreatment in locally recurrent nasopharyngeal carcinoma: Current status and perspectives
por: Poh, Sharon Shuxian, et al.
Publicado: (2021)

Immunotherapy for Urothelial Carcinoma: Current Status and Perspectives
por: Kitamura, Hiroshi, et al.
Publicado: (2011)

Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives
por: Lang, Jinyi, et al.
Publicado: (2019)

OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis
por: Di, Muping, et al.
Publicado: (2022)

Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
por: Zhong, Cheng, et al.
Publicado: (2021)

Current Status in Rechallenge of Immunotherapy
por: Hu, Han, et al.
Publicado: (2023)

Current Status and Future Perspectives about Molecular Biomarkers of Nasopharyngeal Carcinoma
por: Siak, Pui Yan, et al.
Publicado: (2021)

A New Immunological Prognostic Model Based on Immunohistochemistry for Extranodal Natural Killer/T-Cell Lymphoma Patients After Non-Anthracycline-Based Chemotherapy
por: Lam, Sio Teng, et al.
Publicado: (2020)

Immunotherapy for hepatocellular carcinoma: current status and future perspectives
por: Okusaka, Takuji, et al.
Publicado: (2018)

Immunotherapy for hepatocellular carcinoma: Current status and future perspectives
por: Mandlik, Deepa S, et al.
Publicado: (2023)

Immunotherapy for B-Cell Lymphoma: Current Status and Prospective Advances
por: Hollander, Nurit
Publicado: (2012)

Ex vivo expansion of tumor-infiltrating lymphocytes from nasopharyngeal carcinoma patients for adoptive immunotherapy
por: He, Jia, et al.
Publicado: (2012)

The Current Status and Future Prospects for Conversion Therapy in the Treatment of Hepatocellular Carcinoma
por: Bai, Jinfeng, et al.
Publicado: (2023)

Current Status of Cancer Care for Young Patients with Nasopharyngeal Carcinoma in Jakarta, Indonesia
por: Adham, Marlinda, et al.
Publicado: (2014)

A new approach for cellular immunotherapy of nasopharyngeal carcinoma
por: Smith, Corey, et al.
Publicado: (2012)

A Prospective Study: Current Problems in Radiotherapy for Nasopharyngeal Carcinoma in Yogyakarta, Indonesia
por: Stoker, Sharon D., et al.
Publicado: (2014)

The Impact of Insurance and Marital Status on Survival in Patients with Nasopharyngeal Carcinoma
por: Wang, Chih-Chun, et al.
Publicado: (2020)

Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy
por: Li, Jiang, et al.
Publicado: (2007)

Long-term Survivals, Toxicities and the Role of Chemotherapy in Early-Stage Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy: A Retrospective Study with 15-Year Follow-up
por: Wang, Lin, et al.
Publicado: (2022)

Current status of cancer immunotherapy
por: Kono, K
Publicado: (2014)

Lymphoma Immunotherapy: Current Status
por: Zappasodi, Roberta, et al.
Publicado: (2015)

Current Status and Future Directions of Immunotherapies in Soft Tissue Sarcomas
por: Kerrison, William G. J., et al.
Publicado: (2022)

Immunophenotyping at the Time of Diagnosis Distinguishes Two Groups of Nasopharyngeal Carcinoma Patients: Implications for Adoptive Immunotherapy
por: Li, Jiang, et al.
Publicado: (2011)

Current Management Strategy of Nasopharyngeal Carcinoma
por: Wei, William I., et al.
Publicado: (2010)

Current Radiotherapy Considerations for Nasopharyngeal Carcinoma †
por: Ng, Wai Tong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3trrli6rru0626be8l17k03vo7